Strategy & Business model
Biocross’ activity is centered firmly on R&D; the company has positioned itself as a developer of diagnostic systems for neurodegenerative diseases to be marketed by a strategic partner in the in vitro diagnostics or pharmaceutical sector.
Our business model is designed to secure the value of Biocross’ intellectual property and know-how. Biocross is focused on generating a product pipeline to offer investors great benefits with reduced risks and the possibility of near-term revenue generation.
The development of strategic partnerships and alliances represents a key challenge for Biocross. The development of strategic partnerships and alliances represents a key challenge for Biocross, and is of the utmost importance given the continuous changes occuring within the field of neurology.
If you have any questions or comments, we will be pleased to attend you
If you have any questions or comments,
we will be pleased to attend you
Avda. Francisco Vallés, 8
47151 Boecillo (Valladolid) - Spain
+34 983 54 98 96